Remove CMS Remove Heart Attack Remove Heart attacks
article thumbnail

20 hospitals with the lowest, highest heart attack death rates

Becker's Hospital Review - Cardiology

Discover the top hospitals with the lowest and highest death rates for heart attack patients, according to CMS data. NYU Langone Hospitals ranks #1

article thumbnail

Hospitals with highest, lowest 30-day mortality rates for heart attack patients

Becker's Hospital Review - Cardiology

New York City-based NYU Langone hospital had the lowest 30-day mortality rate for heart attack patients in the U.S. between July 1, 2020 and June 30, 2023, according to CMS data released July 31.

article thumbnail

Hospitals with highest, lowest heart attack readmission rates

Becker's Hospital Review - Cardiology

Two Michigan hospitals had the highest excess readmission ratios for heart attack patients in the U.S. between July 1, 2019, and June 30, 2022, according to CMS data released July 31.

article thumbnail

Hospitals with the lowest readmission rates for heart attack patients

Becker's Hospital Review - Cardiology

Discover the hospitals with the highest and lowest hospital return days for heart attack patients, according to CMS data collected from July 2019 to June 2022.

article thumbnail

Weight Loss Drugs Land Medicare Coverage for Cardiovascular Events

CardiacWire

Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.

article thumbnail

Bridging the Gap: Enhancing Stroke Recovery Through Digital Health Solutions

DAIC

I had had a heart attack previously. Navigating Post-Stroke Recovery at Home: One Patient's Experience A ”mildly impaired” stroke patient with atrial fibrillation who was discharged reported, “I knew my local pharmacist, and they knew my prescriptions. I couldn’t dispense my medications into daily doses.

Stroke 115
article thumbnail

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

DAIC

Patients treated with CardiAMP cell therapy saw an almost 5% lower rate of heart death equivalents at up to two years compared to control patients treated with heart failure medication alone (8.3% The CardiAMP HF II trial is expected to similarly secure CMS reimbursement. vs. 13.2%, respectively).